Author
Listed:
- Kyle J. Lorentsen
(University of Florida)
- Jonathan J. Cho
(University of Florida
University of Florida College of Medicine)
- Xiaoping Luo
(University of Florida
University of Florida College of Medicine)
- Ashley N. Zuniga
(University of Florida
University of Florida College of Medicine)
- Joseph F. Urban
(US Department of Agriculture)
- Liang Zhou
(University of Florida
University of Florida)
- Raad Gharaibeh
(University of Florida
University of Florida)
- Christian Jobin
(University of Florida
University of Florida)
- Michael P. Kladde
(University of Florida
University of Florida)
- Dorina Avram
(University of Florida
University of Florida College of Medicine
University of Florida)
Abstract
During helminth infection and allergic asthma, naive CD4+ T-cells differentiate into cytokine-producing Type-2 helper (Th2) cells that resolve the infection or induce asthma-associated pathology. Mechanisms regulating the Th2 differentiation in vivo remain poorly understood. Here we report that mice lacking Bcl11b in mature T-cells have a diminished capacity to mount Th2 responses during helminth infection and allergic asthma, showing reduced Th2 cytokines and Gata3, and elevated Runx3. We provide evidence that Bcl11b is required to maintain chromatin accessibility at Th2-cytokine promoters and locus-control regions, and binds the Il4 HS IV silencer, reducing its accessibility. Bcl11b also binds Gata3-intronic and downstream-noncoding sites, sustaining the Gata3 expression. In addition, Bcl11b binds and deactivates upstream enhancers at Runx3 locus, restricting the Runx3 expression and its availability to act at the Il4 HS IV silencer. Thus, our results establish novel roles for Bcl11b in the regulatory loop that licenses Th2 program in vivo.
Suggested Citation
Kyle J. Lorentsen & Jonathan J. Cho & Xiaoping Luo & Ashley N. Zuniga & Joseph F. Urban & Liang Zhou & Raad Gharaibeh & Christian Jobin & Michael P. Kladde & Dorina Avram, 2018.
"Bcl11b is essential for licensing Th2 differentiation during helminth infection and allergic asthma,"
Nature Communications, Nature, vol. 9(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-04111-0
DOI: 10.1038/s41467-018-04111-0
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-04111-0. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.